ESAM

ESAM is an immunoglobulin-superfamily adhesion molecule that operates at endothelial junctions and at platelet contacts to regulate vascular barrier integrity, inflammatory cell trafficking, and thrombus stability (PMID:16818677, PMID:31826650). At endothelial tight junctions ESAM anchors the multidomain scaffold MAGI-1 through a C-terminal PDZ-mediated interaction, and ESAM is required to recruit MAGI-1 to cell-cell contacts (PMID:15383320). Endothelial ESAM supports neutrophil extravasation downstream of an activated Rho GTPase signal at the junction — acting on the diapedesis step rather than rolling or adhesion — and contributes to VEGF-induced vascular permeability (PMID:16818677). ESAM maintains barrier integrity in a tissue-restricted manner, with permeability defects in the lung; combined loss of ESAM and VE-cadherin causes ultrastructural junction disruption, pulmonary coagulation, and rapid lethality, defining a cooperative role with VE-cadherin not shared by JAM-A or PECAM-1 (PMID:31826650). In platelets, ESAM is stored in alpha granules and translocates to platelet-platelet contact junctions upon activation, where it binds the scaffold NHERF-1 and limits thrombus growth and stability without altering calcium mobilization, integrin activation, or granule secretion (PMID:19740102). ESAM is also functionally indispensable for hematopoietic stem cell-mediated re-establishment of homeostatic hematopoiesis after bone marrow injury (PMID:22649198). Bi-allelic loss-of-function variants in ESAM impair endothelial tubulogenesis and cause defective brain vascular integrity in humans (PMID:36996813).

1. 2004 High

   Established the first molecular partner of ESAM, showing how an endothelial junctional protein could organize an intracellular scaffold at cell contacts.

   Evidence Yeast two-hybrid, pull-down, and Co-IP in transfected CHO cells with colocalization in HUVECs and mouse endothelium

   PMID:15383320

   Open questions at the time

   • Does not define the downstream signaling consequence of MAGI-1 recruitment
   • Functional role of the ESAM-MAGI-1 complex in vivo not tested
2. 2006 High

   Resolved which step of leukocyte trafficking ESAM controls and linked endothelial ESAM to Rho GTPase activation, distinguishing diapedesis from adhesion.

   Evidence ESAM-/- mice, intravital microscopy, peritonitis model, endothelial siRNA knockdown, Rho activation assay, and VEGF permeability assay

   PMID:16818677

   Open questions at the time

   • Mechanism connecting ESAM to Rho activation not defined
   • Whether MAGI-1 mediates the Rho effect untested
3. 2009 High

   Defined a platelet-intrinsic role for ESAM in limiting thrombus growth and identified its platelet scaffold partner, separating it from the general platelet activation machinery.

   Evidence ESAM-/- mice, laser injury thrombosis and tail transection assays, in vitro aggregation, PDZ domain array, and Co-IP; immunofluorescence of resting vs activated platelets

   PMID:19740102

   Open questions at the time

   • Mechanism by which NHERF-1 binding restrains aggregation not resolved
   • Signaling output of ESAM at platelet contacts unknown
4. 2012 Medium

   Connected ESAM expression to HSC proliferative state and demonstrated it is functionally required for regenerative hematopoiesis after injury.

   Evidence ESAM-/- mice, 5-FU bone marrow injury, cell-cycle analysis, long-term reconstitution transplantation, and immunohistochemistry

   PMID:22649198

   Open questions at the time

   • Molecular mechanism of ESAM in HSC self-renewal not defined
   • Relationship between NF-kB/topoisomerase II correlation and ESAM function unestablished
5. 2019 High

   Showed ESAM cooperates with VE-cadherin for barrier integrity in a tissue-specific (lung) manner, and that its cytoplasmic signaling domains are dispensable for this phenotype.

   Evidence Inducible KO mice, in vivo antibody blockade, tissue-specific permeability assays, electron microscopy, and genetic epistasis with VE-cadherin, JAM-A, and PECAM-1

   PMID:31826650

   Open questions at the time

   • Molecular basis of ESAM/VE-cadherin cooperation unresolved
   • Why the phenotype is lung-restricted not explained
6. 2023 Medium

   Provided human genetic evidence that ESAM loss of function causes defective endothelial tubulogenesis and brain vascular pathology, translating mouse phenotypes to disease.

   Evidence Exome sequencing, in vitro tubulogenesis of patient endothelial colony-forming cells, and patient brain immunostaining

   PMID:36996813

   Open questions at the time

   • Mechanism linking ESAM loss to tubulogenesis failure not defined
   • Genotype-phenotype correlation across patients limited

• How ESAM's junctional scaffold interactions (MAGI-1, NHERF-1) mechanistically couple to Rho GTPase signaling, VE-cadherin cooperation, and HSC regeneration remains unresolved.
• No structural model of ESAM-scaffold complexes
• Signaling pathway downstream of ESAM at junctions not mapped
• Tissue specificity of barrier function unexplained